Japan to introduce self-amplifying mRNA COVID-19 vaccine with a 90% adverse event rate, and the U.S. is next in line

Pharmaceutical companies are exploiting populations year-after-year, fine tuning the name of illnesses annually and marketing new cures that only make people sicker. Beginning this fall, Japan will introduce a self-amplifying mRNA COVID-19 vaccine as part of its vaccination program for the 2024-202…